Steven Robert Pacelli is EVP Managing Director Dexcom V of DEXCOM INC. Currently has a direct ownership of 124,775 shares of DXCM, which is worth approximately $10 Million. The most recent transaction as insider was on Nov 24, 2023, when has been sold 411 shares (Common Stock) at a price of $110.8 per share, resulting in proceeds of $45,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 125K
0% 3M change
0% 12M change
Total Value Held $10 Million

Steven Robert Pacelli Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 24 2023
SELL
Open market or private sale
$45,538 $110.8 p/Share
411 Reduced 0.33%
124,775 Common Stock
Oct 23 2023
SELL
Open market or private sale
$35,243 $85.75 p/Share
411 Reduced 0.33%
125,186 Common Stock
Sep 22 2023
SELL
Open market or private sale
$36,332 $88.4 p/Share
411 Reduced 0.33%
125,597 Common Stock
Aug 23 2023
SELL
Open market or private sale
$43,989 $107.03 p/Share
411 Reduced 0.33%
126,008 Common Stock
Jul 24 2023
SELL
Open market or private sale
$53,798 $130.58 p/Share
412 Reduced 0.32%
126,419 Common Stock
Jul 14 2023
SELL
Open market or private sale
$684,216 $136.0 p/Share
5,031 Reduced 3.82%
126,831 Common Stock
Jun 23 2023
SELL
Open market or private sale
$51,879 $125.92 p/Share
412 Reduced 0.31%
131,862 Common Stock
May 23 2023
SELL
Open market or private sale
$48,883 $118.65 p/Share
412 Reduced 0.31%
132,274 Common Stock
Apr 27 2023
SELL
Open market or private sale
$633,906 $126.0 p/Share
5,031 Reduced 3.65%
132,686 Common Stock
Apr 24 2023
SELL
Open market or private sale
$51,368 $124.68 p/Share
412 Reduced 0.3%
137,717 Common Stock
Mar 23 2023
SELL
Open market or private sale
$633,448 $116.4 p/Share
5,442 Reduced 3.79%
138,129 Common Stock
Mar 10 2023
SELL
Sale (or disposition) back to the issuer
$1,299,926 $111.4 p/Share
11,669 Reduced 7.52%
143,571 Common Stock
Mar 08 2023
BUY
Grant, award, or other acquisition
-
18,776 Added 10.79%
155,240 Common Stock
Feb 23 2023
SELL
Open market or private sale
$45,995 $111.64 p/Share
412 Reduced 0.3%
136,464 Common Stock
Jan 23 2023
SELL
Open market or private sale
$44,438 $107.86 p/Share
412 Reduced 0.3%
136,876 Common Stock
Dec 23 2022
SELL
Open market or private sale
$46,378 $112.57 p/Share
412 Reduced 0.3%
137,288 Common Stock
Aug 23 2022
SELL
Open market or private sale
$84,210 $84.21 p/Share
1,000 Reduced 0.72%
137,700 Common Stock
Jul 25 2022
SELL
Open market or private sale
$83,070 $83.07 p/Share
1,000 Reduced 0.72%
138,700 Common Stock
Jun 23 2022
SELL
Open market or private sale
$72,550 $72.55 p/Share
1,000 Reduced 0.71%
139,700 Common Stock
May 24 2022
SELL
Open market or private sale
$74,082 $296.33 p/Share
250 Reduced 0.71%
35,175 Common Stock
Apr 25 2022
SELL
Open market or private sale
$109,985 $439.94 p/Share
250 Reduced 0.7%
35,425 Common Stock
Mar 23 2022
SELL
Open market or private sale
$114,995 $459.98 p/Share
250 Reduced 0.7%
35,675 Common Stock
Mar 09 2022
SELL
Sale (or disposition) back to the issuer
$1,392,380 $406.06 p/Share
3,429 Reduced 8.71%
35,925 Common Stock
Mar 08 2022
BUY
Grant, award, or other acquisition
-
4,984 Added 11.24%
39,354 Common Stock
Feb 23 2022
SELL
Open market or private sale
$98,582 $394.33 p/Share
250 Reduced 0.72%
34,370 Common Stock

Also insider at

OSA
LAAA Merger Corp.
SRP

Steven Robert Pacelli

EVP Managing Director Dexcom V
San Diego, CA

Track Institutional and Insider Activities on DXCM

Follow DEXCOM INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DXCM shares.

Notify only if

Insider Trading

Get notified when an Dexcom Inc insider buys or sells DXCM shares.

Notify only if

News

Receive news related to DEXCOM INC

Track Activities on DXCM